Media coverage
9
Media coverage
Title Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet Morningstar.com Country/Territory United States Date 31/10/23 URL https://www.morningstar.com/news/globe-newswire/8968922/nuwellis-strategic-partner-seastar-medical-receives-fda-approvable-letter-for-its-pediatric-selective-cytopheretic-device Persons Kevin Chung Title Nuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter For Its Pediatric Selective Cytopheretic Device Media name/outlet BENZINGA Newswire Country/Territory United States Date 31/10/23 Persons Kevin Chung Title Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet Street Insider Country/Territory United States Date 31/10/23 URL https://www.streetinsider.com/Press+Releases/Nuwellis%E2%80%99+Strategic+Partner%2C+SeaStar+Medical%2C+Receives+FDA+Approvable+Letter+for+Its+Pediatric+Selective+Cytopheretic+Device/22335789.html Persons Kevin Chung Title Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet ADVFN UK Country/Territory United Kingdom Date 31/10/23 URL https://uk.advfn.com/stock-market/NASDAQ/NUWE/share-news/Nuwellis-Strategic-Partner-SeaStar-Medical-Rec/92412702 Persons Kevin Chung Title Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet Yahoo! Finance Country/Territory United States Date 31/10/23 URL https://finance.yahoo.com/news/nuwellis-strategic-partner-seastar-medical-120000019.html Persons Kevin Chung Title Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet ADVFN US Country/Territory United States Date 31/10/23 URL https://www.advfn.com/stock-market/NASDAQ/NUWE/stock-news/92412702/nuwellis-strategic-partner-seastar-medical-receives-fda-approvable-letter-fo Persons Kevin Chung Title Nuwellis Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet Market News Publishing Country/Territory United States Date 31/10/23 Persons Kevin Chung Title Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet GlobeNewswire Country/Territory United States Date 31/10/23 URL https://www.globenewswire.com/news-release/2023/10/31/2770127/26106/en/Nuwellis-Strategic-Partner-SeaStar-Medical-Receives-FDA-Approvable-Letter-for-Its-Pediatric-Selective-Cytopheretic-Device.html Persons Kevin Chung Title Nuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device Media name/outlet BizWire Express Country/Territory India Date 31/10/23 URL https://www.bizwireexpress.com/showstoryGNW.php?storyid=699317 Persons Kevin Chung